DNA Testing Applied to Fibromyalgia Syndrome Analysis and Management

Abstract

The Fibromyalgia syndrome (FMS) is a very complex condition with a relevant clinical heterogeneity. Considering this premise, the present paper interprets this heterogeneity as the result from differences in individual genetic makeup (genetic polymorphisms) and a constant interaction gene-gene and gene-environment. This paper proposed a method based on the detection of a genetic profile as an additional analytical tool to incorporate in a clinical protocol with the aim to individualize the FMS management.